Walleye Trading LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$180,880
-97.3%
11,200
-89.9%
0.00%
-100.0%
Q1 2023$6,693,101
+525.0%
111,292
+662.3%
0.01%
+250.0%
Q4 2022$1,070,910
-46.8%
14,600
-44.9%
0.00%
-33.3%
Q3 2022$2,014,000
+28.8%
26,500
+17.8%
0.01%
+20.0%
Q2 2022$1,564,000
-47.7%
22,500
-37.7%
0.01%
-44.4%
Q1 2022$2,991,000
+4.6%
36,100
-5.2%
0.01%
-10.0%
Q4 2021$2,859,000
-40.3%
38,086
-7.7%
0.01%
-44.4%
Q3 2021$4,792,000
-9.6%
41,249
+72.6%
0.02%
-14.3%
Q2 2021$5,303,000
+798.8%
23,904
+435.1%
0.02%
+950.0%
Q1 2021$590,000
-95.8%
4,467
-94.5%
0.00%
-96.7%
Q4 2020$13,947,000
-21.3%
80,600
-49.4%
0.06%
-36.8%
Q3 2020$17,721,000
+1710.1%
159,200
+863.5%
0.10%
+1257.1%
Q2 2020$979,000
-8.6%
16,523
+3.9%
0.01%
-12.5%
Q1 2020$1,071,000
-23.2%
15,903
-4.0%
0.01%
-11.1%
Q4 2019$1,395,000
-77.3%
16,559
-79.9%
0.01%
-83.0%
Q3 2019$6,152,000
+72.3%
82,253
+45.6%
0.05%
+71.0%
Q2 2019$3,571,000
-27.5%
56,489
-44.8%
0.03%
-18.4%
Q1 2019$4,927,000
+236.1%
102,300
+133.6%
0.04%
+245.5%
Q4 2018$1,466,000
-43.4%
43,793
-11.4%
0.01%
-15.4%
Q3 2018$2,589,000
+768.8%
49,400
+420.0%
0.01%
+1200.0%
Q2 2018$298,000
-97.4%
9,500
-98.2%
0.00%
-98.5%
Q1 2018$11,669,000
+1803.6%
535,300
+1660.9%
0.07%
+2133.3%
Q4 2017$613,00030,4000.00%
Other shareholders
NOVOCURE LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Nordwand Advisors, LLC 1,515,000$111,125,24913.86%
Invus Financial Advisors, LLC 350,884$25,737,34113.70%
HARTLINE INVESTMENT CORP/ 304,482$22,333,7555.08%
GREAT POINT PARTNERS LLC 241,000$17,677,3503.46%
Tri Locum Partners LP 72,400$5,311,0002.15%
Taylor Frigon Capital Management LLC 42,061$3,085,1741.75%
HighVista Strategies LLC 28,007$2,054,3131.22%
HAP Trading, LLC 124,500$10,2941.05%
Private Harbour Investment Management & Counsel, LLC 12,285$901,1050.99%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 32,000$2,344,0000.72%
View complete list of NOVOCURE LTD shareholders